TRANSFORM STUDY: IMPACT OF DONOR TYPE ON 12-MONTH OUTCOMES OF EVEROLIMUS AND REDUCED CALCINEURIN INHIBITOR VERSUS MYCOPHENOLATE AND STANDARD CALCINEURIN INHIBITOR IN DE NOVO KIDNEY TRANSPLANT PATIENTS
Author(s):
Berger, S.; Sommerer, C.; Bakr, M.; Kim, M.S.; Danguilan, R.; Fijter, J. de; Henry, M.; Luo, W.L.; Bernhardt, P.; Legendre, C.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-09-30
Language
English
Is part of
Transplant International (2017), Vol. 30, p. 162-163
